Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
15.18
+0.10 (0.66%)
Sep 16, 2025, 1:52 PM EDT - Market open
Embecta Employees
Embecta had 2,100 employees as of September 30, 2024. The number of employees decreased by 100 or -4.55% compared to the previous year.
Employees
2,100
Change (1Y)
-100
Growth (1Y)
-4.55%
Revenue / Employee
$525,000
Profits / Employee
$39,810
Market Cap
887.80M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 2,100 | -100 | -4.55% |
Sep 30, 2023 | 2,200 | 300 | 15.79% |
Sep 30, 2022 | 1,900 | -129 | -6.36% |
Sep 30, 2021 | 2,029 | -298 | -12.81% |
Sep 30, 2020 | 2,327 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EMBC News
- 16 days ago - Upgrading Embecta Due To Reorganization And Growth Initiatives - Seeking Alpha
- 19 days ago - Embecta: Strategic Reprioritization Holds Promise And Valuations Are Favorable - Seeking Alpha
- 20 days ago - embecta to Participate in Investor Events - GlobeNewsWire
- 5 weeks ago - Embecta Corp. (EMBC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire
- 7 weeks ago - embecta to Report Fiscal Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day - GlobeNewsWire